Shirin Moshiri Gulledge alias The Spine-to-Stack Shop

Shirin Moshiri Gulledge is not approved to offer acupuncture within a Chiropractor scope of practice under Kansas State Board of Healing Arts (Chiropractic).

acupuncture

Supports

High-quality evidence supports acupuncture having measurable benefits for certain specific conditions, though not as a universal treatment for all health problems. A systematic review and meta-analysis protocol has been initiated to evaluate acupuncture for uremic pruritus, reflecting recognition of its potential and the need for rigorous evidence, but this protocol does not yet provide efficacy data itself . ^[1][6][8] For post-stroke fatigue, a systematic review and meta-analysis of randomized controlled trials reports that acupuncture therapy can significantly reduce fatigue severity compared with control interventions, although heterogeneity and variable trial quality mean results should be interpreted cautiously . ^[2][5][7] For postpartum depression, a systematic review and meta-analysis found that acupuncture, often as an adjunct to usual care, was associated with improvements in depressive symptom scores, suggesting a possible benefit but again based on studies with mixed methodological quality . ^[3] In vitiligo, an overview of systematic reviews and meta-analyses indicates some positive findings for acupuncture as part of integrative regimens, but emphasizes that the underlying trials are small and at risk of bias, so conclusions remain tentative . ^[4] Beyond the indexed papers provided, recent systematic reviews and meta-analyses show evidence of benefit of acupuncture for some pain conditions (including musculoskeletal and perioperative pain), insomnia, certain aspects of COPD, and as an adjunct therapy in type 2 diabetes, with effect sizes that are small to moderate and with safety generally acceptable according to these reviews.

Contradicts

The available evidence does not support a blanket claim that acupuncture is broadly effective for all or most medical conditions. Several systematic reviews note substantial methodological problems in the acupuncture literature, including inadequate blinding, small sample sizes, poor allocation concealment, and publication bias, which can inflate apparent treatment effects. For some indications, such as chronic pain of various etiologies, large high-quality sham-controlled trials and meta-analyses have found only small differences between real and sham acupuncture that may lack clear clinical relevance, suggesting that nonspecific effects and the treatment ritual account for much of the observed benefit. ^[5][7] In conditions like vitiligo, the overview of systematic reviews concludes that current evidence is weak and inconsistent, and that more rigorous, larger trials are needed before any firm claims can be made about efficacy . ^[4] For postpartum depression, the meta-analysis notes important limitations such as heterogeneity, risk of bias, and limited follow-up, so the findings cannot be taken as definitive proof of robust antidepressant efficacy . ^[3][8] For post-stroke fatigue, although the meta-analysis reports benefit, it also highlights variability in diagnostic criteria, acupuncture protocols, and outcome measures across trials, which undermines confidence in strong claims of effectiveness . ^[1][2][6] The protocol for uremic pruritus underscores that evidence is still being gathered and synthesized, meaning no current high-certainty conclusion about efficacy can be drawn for this indication . Overall, where acupuncture has been tested against well-designed sham or placebo controls, many high-quality studies either show no difference or only marginal benefit, which contradicts any sweeping claim that acupuncture is generally effective across a wide range of diseases.

Mainstream view

Mainstream medical and scientific opinion views acupuncture as a complementary or adjunctive therapy with possible modest benefits for specific conditions, especially certain pain syndromes and symptom relief, but not as a universally effective or curative treatment. ^[4][5][6] Major guidelines in pain and rehabilitation medicine typically place acupuncture as an option that may be considered for chronic low back pain, some musculoskeletal pain, and post-stroke symptoms, usually with phrasing that emphasizes limited or moderate-quality evidence, small to moderate effect sizes, and the importance of patient preference and shared decision-making. For psychiatric and neurological conditions such as postpartum depression and post-stroke fatigue, mainstream bodies generally regard the evidence as preliminary and insufficient to recommend acupuncture as a primary treatment, but may acknowledge it as a possible adjunct under appropriate clinical supervision . ^[2][3][8] In dermatologic and systemic diseases such as vitiligo, diabetic nephropathy, and uremic pruritus, the dominant view is that acupuncture should be considered experimental; any use is typically within research settings or integrative medicine programs, with clear communication to patients that evidence is limited and standard therapies remain first-line . ^[1] Overall, mainstream medicine accepts that acupuncture can be safe when properly delivered and may provide symptom relief in some contexts, but it does not endorse broad claims of strong, disease-modifying efficacy across diverse conditions. ^[7] Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

In their own wordsView sourceArchived copy

“acupuncture”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Shirin Moshiri Gulledge is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure weight loss services.

weight loss services

Supports

The general concept of professional weight loss services that include structured lifestyle interventions, pharmacologic therapy, and (in selected cases) bariatric surgery is strongly supported by multiple high‑quality guidelines and systematic reviews. Intensive, multicomponent behavioral interventions for adults with BMI ≥30 kg/m² are recommended by major guideline bodies as effective for clinically meaningful weight loss and risk factor improvement, consistent with the US Preventive Services Task Force statement that clinicians should offer or refer such adults to intensive behavioral programs.^[15] Lifestyle modification (diet, physical activity, behavioral therapy) is consistently described as the cornerstone of obesity management, with pharmacologic and sometimes surgical approaches used as adjuncts when lifestyle alone is insufficient.^{[11][12][16][18][19]} Contemporary guidelines from organizations such as the American College of Physicians, gastroenterology and obesity societies recommend evidence‑based anti‑obesity medications (e.g., GLP‑1 receptor agonists like semaglutide, dual incretin agonists like tirzepatide, and other agents) for adults with BMI ≥30 or ≥27 with comorbidities who fail lifestyle interventions, showing clinically meaningful and often substantial weight loss and cardiometabolic benefit.^{[8][9][12][13][14][16][18][19]} Bariatric surgery is endorsed as the most effective long‑term option for severe obesity when combined with lifestyle and, in some cases, pharmacotherapy, supported by clinical practice guidelines and reviews focusing on specific populations such as menopausal women and adolescents.^[3][4][17] Overall, there is strong evidence that medically supervised, guideline‑driven weight loss services improve weight, metabolic risk factors, and obesity‑related health outcomes and should be delivered using a structured, person‑centered, multidisciplinary approach.^{[5][6][9][16][18][19]}

Contradicts

While weight loss services are broadly supported, evidence and guidelines also highlight important limitations that contradict overly simplistic or universal claims. Guidelines emphasize that lifestyle programs alone often have limited long‑term effectiveness and durability for many people, with modest average weight loss and common weight regain, so services that promise dramatic or permanent weight loss from lifestyle change alone are not well supported.^[5][16][18] Pharmacologic weight loss services are recommended only for clearly defined indications (BMI thresholds and comorbidities) and must be used as adjuncts to lifestyle, not as stand‑alone quick fixes; guideline panels note concerns about side effects, cost, access, adherence, and weight regain after discontinuation, which contradict marketing that portrays medications as risk‑free or one‑time cures.^{[5][8][9][12][14][17][18][19]} Some drugs historically used for weight loss have limited evidence or safety concerns, and high‑quality guidelines explicitly recommend against or restrict certain agents (e.g., orlistat or compounded/unsupported preparations), so services that rely on non‑approved, compounded, or poorly studied medications fall outside evidence‑based practice.^{[9][14][17][19]} Evidence is weaker or lacking in specific populations, such as adolescents after bariatric surgery, where systematic reviews report a paucity of data on pharmacotherapy in this subgroup, limiting strong claims about the effectiveness of such combined services.^[4] Overall, the literature contradicts any claim that generic “weight loss services” are uniformly effective or appropriate for everyone; effectiveness depends on intensity, modality, adherence, appropriate patient selection, and long‑term follow‑up, and any service that ignores these constraints is not evidence‑based.^{[5][9][15][16][18][19]}

Mainstream view

The mainstream medical position is that obesity is a chronic, relapsing disease requiring long‑term, structured management, and that evidence‑based weight loss services should be multidisciplinary, guideline‑driven, and tailored to individual risk and preferences. Standard care begins with intensive lifestyle interventions—dietary change, increased physical activity, and behavioral therapy—as the foundation of treatment, delivered through structured programs for patients with obesity and often provided via specialized weight management services.^{[11][12][15][16][19]} When lifestyle measures alone do not achieve clinically meaningful weight loss (typically ≥5% of baseline weight), current guidelines support adding approved anti‑obesity pharmacotherapy for adults meeting BMI and comorbidity criteria, with GLP‑1 and dual GIP/GLP‑1 agonists now considered first‑line agents in many guidelines because of their superior efficacy and cardiometabolic benefits.^{[8][9][12][13][14][16][18][19]} Bariatric surgery is recognized as the most effective intervention for severe obesity, but it is reserved for selected patients and integrated into broader services

In their own wordsView sourceArchived copy

“weight loss services”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Shirin Moshiri Gulledge is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise uncover the cause of your health complaints as within their scope of practice.

uncover the cause of your health complaints

Supports

High-quality evidence supports the general clinical process of uncovering causes of health complaints through careful history, physical examination, and targeted testing; a systematic framework can reduce missed diagnoses and improve diagnostic reasoning. ^[20] The indexed guideline-style source on systematic diagnosis explicitly describes gathering a comprehensive history, performing a focused exam, and refining a differential diagnosis with evidence-based testing . Another indexed source on patient complaints notes they can be used systematically to identify diagnostic safety concerns, though this is about safety signal detection rather than definitive diagnosis . ^[19] The broader diagnostic-literature source also supports using a reference standard and structured review methods when evaluating diagnostic accuracy, which is consistent with careful cause-finding in clinical practice . ^[17][18]

Contradicts

The claim is extremely broad and not itself a testable medical assertion; it does not specify a condition, symptom set, population, or intervention, so there is no direct trial or meta-analytic evidence proving that one can generally 'uncover the cause' of all health complaints. ^[17][19] The indexed papers provided do not directly study this exact claim, and most are unrelated to symptom-cause evaluation. The evidence base for diagnostic reasoning is strong in general, but the ability to identify the cause of every complaint is limited by nonspecific symptoms, incomplete histories, overlapping conditions, and cases where no clear organic cause is found even after workup. The systematic-review source on diagnostic studies emphasizes the need for a reference standard and complete participant definitions, underscoring that diagnostic certainty depends heavily on context and available comparators . ^[18][20]

Mainstream view

Mainstream medicine supports a structured diagnostic workup to investigate health complaints and identify likely causes when possible. ^[19][20] Clinicians use history, examination, differential diagnosis, and targeted tests, but they do not claim that every complaint has an immediately discoverable or single cause. In practice, the mainstream view is that symptom evaluation can often clarify etiology, but some complaints remain multifactorial, functional, idiopathic, or unresolved despite appropriate assessment . ^[18] Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

In their own wordsView sourceArchived copy

“Our goal is to uncover the cause of your health complaints and fix it so that you can do the things you love to do in life.”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Shirin Moshiri Gulledge is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise we are experts at diagnosing, managing and treating this as within their scope of practice.

we are experts at diagnosing, managing and treating this

Supports

Clinical practice guidelines and consensus statements are typically developed by multidisciplinary panels of clinicians who are considered experts in diagnosing, managing, and treating specific conditions, which supports the general idea that organized specialty groups can legitimately claim expertise in their domain. ^[21][24][26] Guidelines on hypertension, diverticulitis, and musculoskeletal pain similarly rely on expert panels using systematic reviews and evidence-based methods to produce recommendations that assume a high level of diagnostic and management competence among the contributing clinicians. ^[22][9][23] Conceptual work on clinical expertise in evidence-based practice emphasizes that experienced clinicians integrate research evidence, clinical state, and patient preferences, providing a framework in which some clinicians legitimately function as experts at diagnosis and management. ^[27] Papers on identifying experts for guideline panels describe expertise as a combination of domain knowledge, experience, and methodological skill, again supporting the notion that recognized experts exist and can credibly participate in complex diagnostic and treatment decisions.

Contradicts

Major guideline and methodology papers emphasize that expertise alone is not sufficient; trustworthy care must be grounded in systematic evidence review, transparent processes, and consideration of patient preferences, which undercuts blanket assertions of expertise that do not reference these elements. ^[22][9][27] Work on identifying experts explicitly notes there is no universally accepted definition or validated method to select experts, and that commonly used proxies such as publications or tenure are imperfect, so broad claims of being experts may be weakly supported or context dependent. Studies on expert opinion in guidelines argue that expert judgment is often needed when evidence is low but should not be treated as a separate, high-level evidence category, highlighting that expert claims must be interpreted cautiously rather than accepted as strong evidence by themselves. Methodological discussions on evidence hierarchies show expert opinion is the lowest formal level of evidence, reinforcing that claims of expertise do not, by themselves, guarantee high-quality diagnostic or treatment performance.

Mainstream view

The mainstream evidence-based medicine position is that clinical expertise is real and important, but it must be integrated with high-quality research evidence and patient values rather than standing alone as justification for care. ^[22][9][27] Trustworthy clinical practice guidelines are expected to be developed by knowledgeable, multidisciplinary expert panels using systematic reviews and explicit methods, reflecting a consensus that expertise is valuable when combined with rigorous evidence appraisal. ^{[21][23][24][26]} At the same time, mainstream methodology recognizes there is no single gold-standard definition of an expert, and expert opinion ranks below systematic reviews and randomized trials in evidentiary strength, so unsupported self-descriptions of being “experts” are viewed as marketing rather than evidence. Overall, the accepted view is that clinicians and organizations can reasonably claim expertise in narrowly defined areas when they adhere to guideline-level standards of evidence integration and transparent processes, but such claims should be critically evaluated rather than taken at face value.

In their own wordsView sourceArchived copy

“we are experts at diagnosing, managing and treating this”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Shirin Moshiri Gulledge is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure HEADACHES OR MIGRAINES?.

HEADACHES OR MIGRAINES?

Supports

The indexed BMJ systematic review and network meta-analysis shows that multiple licensed oral drugs (including triptans and NSAIDs) are effective for the acute treatment of migraine episodes in adults, improving pain freedom at two hours and sustained pain freedom to 24 hours. ^{[30][33][34][35][36]} This provides strong RCT-based evidence that pharmacologic treatment can meaningfully reduce migraine headache symptoms. The systematic review and meta-analysis on vitamin B2 (riboflavin) prophylaxis finds that 400 mg/day for three months significantly reduces the days, duration, frequency, and pain scores of migraine attacks, supporting a role for certain nutritional interventions in reducing migraine burden. ^[31] The epidemiologic systematic review and meta-analysis in children and adolescents confirms that primary headaches, including migraine, are common and clinically significant in younger populations, reinforcing that headaches/migraines are recognized medical conditions with substantial prevalence and impact. ^[32] Current guideline-driven management of hypertension discusses blood pressure control as part of broader cardiovascular risk reduction, and while not focused on migraine, it aligns with mainstream guidance that vascular risk factors are medically important in patients with migraine with aura. ^[9]

Contradicts

None of the indexed high-quality papers suggest that headaches or migraines are trivial or not real conditions; instead, they consistently treat migraine as a significant neurologic disorder requiring evidence-based management. ^[9] The BMJ network meta-analysis emphasizes that some newer agents (lasmiditan, rimegepant, ubrogepant) are less efficacious than the best-performing triptans, contradicting any blanket claim that newer drugs are universally superior for migraine headaches. ^{[30][33][34][35][36]} The vitamin B2 meta-analysis, while supportive of benefit, is based on a limited number of trials and therefore does not justify overinflated claims that riboflavin alone will cure migraines; the evidence supports modest prophylactic benefit rather than complete resolution. ^[31] The epidemiology review shows high prevalence but does not support claims that all headaches are migraines or that a single mechanism or treatment applies universally across headache types; tension-type and other primary headaches remain distinct entities. ^[32]

Mainstream view

Mainstream medical and scientific consensus is that migraine is a common, disabling primary headache disorder with characteristic features (e. g. , throbbing pain, nausea, photophobia), distinct from other headache types such as tension-type headache. Evidence-based management involves both acute treatments (triptans, NSAIDs, gepants, ditans, and combination regimens) and preventive strategies (pharmacologic prophylaxis, selected supplements such as riboflavin, lifestyle modification), chosen according to disease severity, comorbidities, and patient preference. ^[9] Large network meta-analyses indicate that certain triptans (particularly eletriptan, rizatriptan, sumatriptan, and zolmitriptan) have the most favorable balance of efficacy and tolerability for acute migraine episodes, and are generally preferred first-line agents in adults without high cardiovascular risk. ^{[30][31][33][34][35][36]} Preventive measures such as vitamin B2 have supportive but not definitive evidence, and are usually considered adjuncts within a broader prophylactic strategy rather than stand-alone cures. Epidemiologic data support that primary headaches and migraines are prevalent across the lifespan, including in children and adolescents, and merit structured assessment and management rather than dismissal as minor complaints. ^[32] Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).

In their own wordsView sourceArchived copy

“HEADACHES OR MIGRAINES?”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)

Shirin Moshiri Gulledge is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure CARPAL TUNNEL?.

CARPAL TUNNEL?

Supports

Carpal tunnel syndrome is a recognized clinical condition with substantial peer-reviewed literature on diagnosis and treatment, including systematic reviews comparing local corticosteroid injection with surgical release and reviews on diagnostic association with carpal tunnel cross-sectional area . These reviews support that carpal tunnel syndrome can be assessed and treated using evidence-based approaches, and that ultrasound-derived cross-sectional area has diagnostic value, although the exact strength varies by study design and threshold .

Contradicts

The claim as written is too vague to evaluate as a substantive medical statement, because it only names a condition and does not make an actionable or testable assertion. The provided index papers do not establish any specific claim about prevention, cure, causation, or a particular treatment for carpal tunnel syndrome. The dentist-prevalence review is about prevalence in a specific occupational group and does not generalize to all patients, and the peer-review records do not add clinical evidence . Evidence comparing steroid injection with surgery addresses treatment options rather than proving one universally superior approach for all cases, so broad influencer-style claims about a single best remedy would be unsupported or overgeneralized .

Mainstream view

Mainstream medical consensus is that carpal tunnel syndrome is a common entrapment neuropathy diagnosed clinically, sometimes supported by electrodiagnostic testing or ultrasound, and managed with splinting, corticosteroid injection, activity modification, and surgical release for persistent or severe cases. High-quality reviews support corticosteroid injection as a short-term option and surgery as an effective definitive treatment for appropriate patients, while no single non-surgical approach is universally curative. Because the user-supplied claim is only the phrase carpal tunnel, there is no specific factual assertion to confirm or refute.

In their own wordsView sourceArchived copy

“CARPAL TUNNEL?”

Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)